REG210 FDA Guidance on Rare Disease Drug Development

The Orphan Drug Act was enacted in 1983 to help make development of drugs for rare diseases more financially viable. The Act DOES NOT create a different statutory standard for rare disease products. This module will help you understand the areas where rare disease drug development differs from traditional drug development.

Related Vocabulary

abcdefghilmnprst

Good Laboratory Practice

large molecules

If you’re already an Atlas member login to start this course.

Not a member? Join now for full access to the Atlas.

Not ready to subscribe to the Atlas for access to unlimited courses?

Buy this course

Price:

$29.99

First Name: First Name Required

Last Name: Last Name Required

Address Line 1:* Address Line 1 is Required

Address Line 2: Address Line 2 is not valid

City:* City is Required

Country:* Country is Required

State/Province:* State/Province is Required

Zip/Postal Code:* Zip/Postal Code is Required

User Name:* User Name is Required

Username:* Invalid Username

Email:* Invalid Email

Password:* Invalid Password

Password Confirmation:* Password Confirmation Doesn’t Match

Have a coupon?

Coupon Code:

Invalid Coupon Coupon applied successfully

Javascript is disabled in your browser. You will not be able to complete your purchase until you either enable JavaScript in your browser, or switch to a browser that supports it.

No val Please fix the errors above

Login